Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis.
Tseng
Guan-Ying
GY
Lin
Hwai-Jeng
HJ
D015746:Abdominal Pain / Q000453:epidemiology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D003430:Cross-Sectional Studies; D004415:Dyspepsia / Q000453:epidemiology; D005767:Gastrointestinal Diseases / Q000453:epidemiology*; D016481:Helicobacter Infections / Q000453:epidemiology; D016480:Helicobacter pylori; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000453:epidemiology; D007676:Kidney Failure, Chronic / Q000453:epidemiology* / Q000628:therapy*; D054368:Laxatives / Q000627:therapeutic use; D008134:Long-Term Care; D010437:Peptic Ulcer / Q000453:epidemiology; D010530:Peritoneal Dialysis; D012008:Recurrence; D006435:Renal Dialysis; D012307:Risk Factors; D014839:Vomiting / Q000453:epidemiology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D054368:Laxatives; D001241:Aspirin